Thrombolytic protocol minimizes ischemic-type biliary complications in liver transplantation from donation after circulatory death donors

Liver Transplantation

Volumn 21, Issue 3, 2015, Pages 321-328

  Seal, John B ^a   Bohorquez, Humberto ^b   Reichman, Trevor ^b   Kressel, Adam ^b   Ghanekar, Anand ^a   Cohen, Ari ^b   McGilvray, Ian D ^a   Cattral, Mark S ^a   Bruce, David ^b   Greig, Paul ^a   Carmody, Ian ^b   Grant, David ^a   Selzner, Markus ^a   Loss, George ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; FRESH FROZEN PLASMA; TISSUE PLASMINOGEN ACTIVATOR; VERAPAMIL; FIBRINOLYTIC AGENT;

ADULT; ARTERY ANASTOMOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLEEDING; BLOOD CLOT LYSIS; CANCER STAGING; CHOLESTASIS; CIRCULATORY DEATH DONOR; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEPATIC ARTERY THROMBOSIS; HUMAN; ISCHEMIA; ISCHEMIC TYPE BILIARY STRICTURE; LIVER TRANSPLANTATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PEROPERATIVE CARE; PRIORITY JOURNAL; RETRANSPLANTATION; RETROSPECTIVE STUDY; TUMOR RECURRENCE; ADVERSE EFFECTS; AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CANADA; CAUSE OF DEATH; CLINICAL TRIAL; DONOR; DONOR SELECTION; FIBRINOLYTIC THERAPY; HEPATIC ARTERY; INTRAARTERIAL DRUG ADMINISTRATION; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RISK FACTOR; TIME; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

ADULT; AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CAUSE OF DEATH; CHOLESTASIS; DONOR SELECTION; FEMALE; FIBRINOLYTIC AGENTS; GRAFT SURVIVAL; HEPATIC ARTERY; HUMANS; INJECTIONS, INTRA-ARTERIAL; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEW ORLEANS; ONTARIO; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE DONORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84923578071     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24071     Document Type: Article

References (21)

1. Foley DP, Fernandez LA, Leverson G, Chin LT, Krieger N, Cooper JT, et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 2005;242:724-731.
2. Callaghan CJ, Charman SC, Muiesan P, Powell JJ, Gimson AE, van der Meulen JHP; for UK Liver Transplant Audit. Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open 2013;3:e003287.
3. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmann JF. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004;239:87-92.
4. Mateo R, Cho Y, Singh G, Stapfer M, Donovan J, Kahn J, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant 2006;6:791-796.
5. Lee KW, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006;82:1683-1688.
6. Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant 2010;10:2512-2519.
7. Jay C, Ladner D, Wang E, Lyuksemburg V, Kang R, Chang Y, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant-an analysis of the national registry. J Hepatol 2011;55:808-813.
8. Axelrod DA, Lentine KL, Xiao H, Dzebisashvilli N, Schnitzler M, Tuttle-Newhall JE, Segev DL. National assessment of early biliary complications following liver transplantation: Incidence and outcomes. Liver Transpl 2014;20:446-456.
9. Orman ES, Barritt AS 4th, Wheeler SB, Hayashi PH. Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transpl 2013;19:59-68.
10. Hashimoto K, Eghtesad B, Gunasekaran G, Fujiki M, Uso TD, Quintini C, et al. Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant 2010;10:2665-2672.
11. Foley DP, Fernandez LA, Leverson G, Anderson M, Mezrich J, Sollinger HW, D'Alessandro A. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long term outcomes from a single center. Ann Surg 2011; 253:817-825.
12. Taner CB, Bulatao IG, Willingham DL, Perry DK, Sibulesky L, Pungpapong S, et al. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl 2012;18:100-111.
13. Harring TR, Nguyen NT, Cotton RT, Guiteau JJ, Salas de Armas IA, Liu H, et al. Liver transplantation with donation after cardiac death donors: A comprehensive update. J Surg Res 2012;178:502-511.
14. Karp SJ, Johnson S, Evenson A, Curry MP, Manning D, Malik R, et al. Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation. HPB (Oxford) 2011;13:411-416.
15. Gunasekaran G, Sharma J, Mosna LC, Bodin R, Wolf DC. Timing of hepatic artery reperfusion and biliary strictures in liver transplantation. J Transplant 2013; 2013:757389.
16. Leiper K, Croll A, Booth NA, Moore NR, Sinclair T, Bennett B. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease. J Clin Pathol 1994;47:214-217.
17. Sakharov DV, Rijken DC. Superficial accumulation of plasminogen during plasma clot lysis. Circulation 1995; 92:1883-1890.
18. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, et al. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl 2009; 15:1028-1035.
19. Leithead JA, Tariciotti L, Gunson B, Holt A, Isaac J, Mirza DF, et al. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury. Am J Transplant 2012;12:965-975.
20. Moreno-Gonzalez E, Meneu-Diaz JG, Fundora Y, Ortega P, Moreno Elola-Olaso A, García García I, et al. Advantages of the piggy back technique on intraoperative transfusion, fluid consumption, and vasoactive drugs requirements in liver transplantation: a comparative study. Transplant Proc 2003;35:1918-1919.
21. Nikeghbalian S, Dehghani M, Salahi H, Bahador A, Kazemi K, Kakaei F, et al. Effects of surgical technique on postoperative renal function after orthotopic liver transplant. Exp Clin Transplant 2009;7:25-27.